Your browser doesn't support javascript.
loading
Incarceration history is associated with HIV infection among community-recruited people who inject drugs in Europe: A propensity-score matched analysis of cross-sectional studies.
Uusküla, Anneli; Rannap, Jürgen; Weijler, Lisa; Abagiu, Adrian; Arendt, Vic; Barrio, Gregorio; Barros, Henrique; Brummer-Korvenkontio, Henrikki; Casabona, Jordi; Croes, Esther; Jarlais, Don Des; Seguin-Devaux, Carole; Dudás, Mária; Eritsyan, Ksenia; Folch, Cinta; Hatzakis, Angelos; Heimer, Robert; Heinsbroek, Ellen; Hope, Vivian; Jipa, Raluca; Kivite-Urtane, Anda; Levina, Olga; Lyubimova, Alexandra; Malczewski, Artur; Matser, Amy; McAuley, Andrew; Meireles, Paula; Mravcík, Viktor; Op de Coul, Eline; Ojavee, Sven E; Parés-Badell, Oleguer; Prins, Maria; Pulido, José; Romanyak, Elena; Rosinska, Magdalena; Seyler, Thomas; Stone, Jack; Sypsa, Vana; Talu, Ave; Tarján, Anna; Taylor, Avril; Vickerman, Peter; Vorobjov, Sigrid; Dolan, Kate; Wiessing, Lucas.
Affiliation
  • Uusküla A; Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.
  • Rannap J; Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.
  • Weijler L; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal.
  • Abagiu A; National Institute for Infectious diseases 'Professor Dr Matei Bals', Bucharest, Romania.
  • Arendt V; Service National des Maladies Infectieuses, Centre Hospitalier de Luxembourg, Luxembourg.
  • Barrio G; National School of Public Health, Carlos III Health Institute, Madrid, Spain.
  • Barros H; EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal.
  • Brummer-Korvenkontio H; Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Casabona J; Centre for Epidemiological Studies on Sexually Transmitted Infections and HIV/AIDS of Catalonia (CEEISCAT), Catalonia Public Health Agency (ASPCAT), Badalona, Spain.
  • Croes E; Biomedical Research Networking Centre in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
  • Jarlais DD; Trimbos Institute, Utrecht, the Netherlands.
  • Seguin-Devaux C; School of Global Public Health, New York University, New York, NY, 10012, USA.
  • Dudás M; Department of Infection and Immunity, Luxembourg Institute of Health, Luxembourg.
  • Eritsyan K; National Public Health Center, Budapest, Hungary.
  • Folch C; National Research University Higher School of Economics, St Petersburg, Russia.
  • Hatzakis A; Centre for Epidemiological Studies on Sexually Transmitted Infections and HIV/AIDS of Catalonia (CEEISCAT), Catalonia Public Health Agency (ASPCAT), Badalona, Spain.
  • Heimer R; Biomedical Research Networking Centre in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
  • Heinsbroek E; Department of Hygiene, Epidemiology and Medical Statistics, National and Kapodistrian University of Athens, Medical School, Athens, Greece.
  • Hope V; Department of the Epidemiology of Microbial Diseases, Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, CT, USA.
  • Jipa R; Blood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London, UK.
  • Kivite-Urtane A; Blood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London, UK.
  • Levina O; Public Health Institute, Liverpool John Moores University, Liverpool, UK.
  • Lyubimova A; National Institute for Infectious diseases 'Professor Dr Matei Bals', Bucharest, Romania.
  • Malczewski A; Institute of Public Health, Riga Stradins University, Riga, Latvia.
  • Matser A; National Research University Higher School of Economics, St Petersburg, Russia.
  • McAuley A; Acuity Systems, Herndon, VA, USA.
  • Meireles P; National Research University Higher School of Economics, St Petersburg, Russia.
  • Mravcík V; EMCDDA Polish National Focal Point, National Bureau for Drug Prevention, Warsaw, Poland.
  • Op de Coul E; Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.
  • Ojavee SE; Amsterdam UMC, University of Amsterdam, Department of Infectious Diseases, Amsterdam Infection andd Immunity Institute, Amsterdam, the Netherlands.
  • Parés-Badell O; Public Health Scotland, Meridian Court, Glasgow, Scotland, UK.
  • Prins M; School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, Scotland, UK.
  • Pulido J; EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal.
  • Romanyak E; Department of Addictology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
  • Rosinska M; Spolecnost Podané ruce, Brno, Czech Republic.
  • Seyler T; Klinika Podané ruce, Brno, Czech Republic.
  • Stone J; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
  • Sypsa V; Department of Computational Biology, University of Lausanne, Lausanne, Switzerland.
  • Talu A; Agència de Salut Pública de Barcelona, Barcelona, Spain.
  • Tarján A; Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.
  • Taylor A; Amsterdam UMC, University of Amsterdam, Department of Infectious Diseases, Amsterdam Infection andd Immunity Institute, Amsterdam, the Netherlands.
  • Vickerman P; National School of Public Health, Carlos III Health Institute, Madrid, Spain.
  • Vorobjov S; Biomedical Research Networking Centre in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
  • Dolan K; Department of Public Health and Maternal and Child Health, Complutense University of Madrid, Madrid, Spain.
  • Wiessing L; Non-Profit Partnership ESVERO, 12, Moscow, Russia.
Addiction ; 118(11): 2177-2192, 2023 11.
Article in En | MEDLINE | ID: mdl-37991429
ABSTRACT

AIMS:

We measured the association between a history of incarceration and HIV positivity among people who inject drugs (PWID) across Europe. DESIGN, SETTING AND

PARTICIPANTS:

This was a cross-sectional, multi-site, multi-year propensity-score matched analysis conducted in Europe. Participants comprised community-recruited PWID who reported a recent injection (within the last 12 months). MEASUREMENTS Data on incarceration history, demographics, substance use, sexual behavior and harm reduction service use originated from cross-sectional studies among PWID in Europe. Our primary outcome was HIV status. Generalized linear mixed models and propensity-score matching were used to compare HIV status between ever- and never-incarcerated PWID.

FINDINGS:

Among 43 807 PWID from 82 studies surveyed (in 22 sites and 13 countries), 58.7% reported having ever been in prison and 7.16% (n = 3099) tested HIV-positive. Incarceration was associated with 30% higher odds of HIV infection [adjusted odds ratio (aOR) = 1.32, 95% confidence interval (CI) = 1.09-1.59]; the association between a history of incarceration and HIV infection was strongest among PWID, with the lowest estimated propensity-score for having a history of incarceration (aOR = 1.78, 95% CI = 1.47-2.16). Additionally, mainly injecting cocaine and/or opioids (aOR = 2.16, 95% CI = 1.33-3.53), increased duration of injecting drugs (per 8 years aOR = 1.31, 95% CI = 1.16-1.48), ever sharing needles/syringes (aOR = 1.91, 95% CI = 1.59-2.28) and increased income inequality among the general population (measured by the Gini index, aOR = 1.34, 95% CI = 1.18-1.51) were associated with a higher odds of HIV infection. Older age (per 8 years aOR = 0.84, 95% CI = 0.76-0.94), male sex (aOR = 0.77, 95% CI = 0.65-0.91) and reporting pharmacies as the main source of clean syringes (aOR = 0.72, 95% CI = 0.59-0.88) were associated with lower odds of HIV positivity.

CONCLUSIONS:

A history of incarceration appears to be independently associated with HIV infection among people who inject drugs (PWID) in Europe, with a stronger effect among PWID with lower probability of incarceration.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Substance Abuse, Intravenous / HIV Seropositivity / Drug Users Limits: Humans / Male Country/Region as subject: Europa Language: En Journal: Addiction Journal subject: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Substance Abuse, Intravenous / HIV Seropositivity / Drug Users Limits: Humans / Male Country/Region as subject: Europa Language: En Journal: Addiction Journal subject: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Year: 2023 Document type: Article Affiliation country: